Acquisition History / Alkem MedTech (Alkem Laboratories Ltd) / Occlutech Holding AG (up to 55%)
Alkem MedTech (Alkem Laboratories Ltd) Acquires Occlutech Holding AG (up to 55%)
Announced February 13, 2026 — $116.3M
What happened
Alkem MedTech, the medical devices arm of Alkem Laboratories, made a binding offer for a controlling stake of up to 55% in Switzerland-based Occlutech Holding AG for EUR 99.4 million. Founded in 2003, Occlutech makes minimally invasive cardiac implants used in congenital heart disease, stroke prevention and heart failure. Completion was expected by June 2026.
- Target
- Occlutech Holding AG (up to 55%)
- Announced
- February 13, 2026
- Price
- $116.3M
- Industry
- Structural heart medical devices
- Buyer type
- Strategic acquirer
- Status
- Announced, not yet closed
By the numbers
Frequently Asked Questions About This Acquisition
When did Alkem MedTech (Alkem Laboratories Ltd) acquire Occlutech Holding AG (up to 55%)?
Alkem MedTech (Alkem Laboratories Ltd) acquired Occlutech Holding AG (up to 55%) on February 13, 2026. This was Alkem MedTech (Alkem Laboratories Ltd)'s 1st publicly tracked acquisition out of 1 we have on record.
How much did Alkem MedTech (Alkem Laboratories Ltd) pay for Occlutech Holding AG (up to 55%)?
Alkem MedTech (Alkem Laboratories Ltd) paid $116.3M for Occlutech Holding AG (up to 55%).
What does Occlutech Holding AG (up to 55%) do?
Alkem MedTech, the medical devices arm of Alkem Laboratories, made a binding offer for a controlling stake of up to 55% in Switzerland-based Occlutech Holding AG for EUR 99.4 million. Founded in 2003, Occlutech makes minimally invasive cardiac implants used in congenital heart disease, stroke prevention and heart failure. Completion was expected by June 2026.
What other Structural heart medical devices companies has Alkem MedTech (Alkem Laboratories Ltd) acquired?
Occlutech Holding AG (up to 55%) is Alkem MedTech (Alkem Laboratories Ltd)'s only publicly tracked acquisition in Structural heart medical devices so far.